Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1090 Records) |
| Query Trace: Ovarian Neoplasms and BRCA2[original query] |
|---|
| Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer. JAMA network open 2024 9 7 (9): e2431427. Zoulikha Rezoug, Stephanie P Totten, David Szlachtycz, Adrienne Atayan, Kristen Mohler, Sophie Albert, Leila Feng, Brianna Lemieux Anglin, Zhen Shen, Daniel Jimenez, Nancy Hamel, Nicholas Meti, Khashayar Esfahani, Jean-François Boileau, Ipshita Prakash, Mark Basik, Sarkis Meterissian, Francine Tremblay, David Fleiszer, Dawn Anderson, George Chong, Stephanie M Wong, William D Foulk |
| Screening Familial Risk for Hereditary Breast and Ovarian Cancer. JAMA network open 2024 9 7 (9): e2435901. Daniel Kiser, Gai Elhanan, Alexandre Bolze, Iva Neveux, Karen A Schlauch, William J Metcalf, Elizabeth T Cirulli, Catherine McCarthy, Leslie A Greenberg, Savanna Grime, Jamie M Schnell Blitstein, William Plauth, Joseph J Grzyms |
| Identification of ubiquitin markers for survival and prognosis of ovarian cancer. Heliyon 2024 9 10 (18): e37288. Yiwen Feng, Liyun Shan, Yanping Gong, Wenzhao Hang, Zhenyu Sang, Yunyan Sun, Kefu Tang, Yulan Wang, Binjie Hu, Xiaowei |
| BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. Molecular cancer 2024 8 23 (1): 158. Ksenija Nesic, John J Krais, Yifan Wang, Cassandra J Vandenberg, Pooja Patel, Kathy Q Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S Penington, Franziska Geissler, Elizabeth Kyran, Robert Betsch, Lijun Xu, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Iain McNeish, Gayanie Ratnayake, Nadia Traficante, , Anna DeFazio, David D L Bowtell, Thomas C Harding, Kevin Lin, Elizabeth M Swisher, Olga Kondrashova, Clare L Scott, Neil Johnson, Matthew J Wakefie |
| The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. Cancer genomics & proteomics 2024 8 21 (5): 448-463. Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, Christina Ntogka, Georgia Pepe, Dimitra Bouzarelou, Athanasios Papathanasiou, Dimitrios Grigoriadis, Georgios N Tsaousis, Helen Gogas, Theodore Troupis, Konstantinos Papazisis, Ioannis Natsiopoulos, Vassileios Venizelos, Kyriakos Amarantidis, Stylianos Giassas, Christos Papadimitriou, Elena Fountzilas, Maroulio Stathoulopoulou, Anna Koumarianou, Grigorios Xepapadakis, Alexandru Blidaru, Daniela Zob, Oana Voinea, Mustafa Özdo?an, Mahmut Çerkez Ergören, Alinta Hegmane, Eirini Papadopoulou, George Nasioulas, Christos Markopoul |
| Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report. Gynecologic oncology 2024 8 190 104-112. Erik Škof, Vida Stegel, Vita Šetraj?i? Dragoš, Ana Blatnik, Brigita Gregori?, Petra Škerl, Gašper Klan?ar, Anja Zagožen Klasinc, Alenka Bomba?, Mateja Krajc, Srdjan Novakov |
| The Role of hBRCA2 in the Repair of Spontaneous and UV DNA Damage in Saccharomyces cerevisiae. microPublication biology 2024 8 2024 . Sherrice Law, David Park, Hannah Park, Hannah Zhang, Damon Mey |
| Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods. Pathology oncology research : POR 2024 8 30 1611813. László Baráti, Anita Maász, Alexandra Mikó, Éva Bércesi, Sultan Al Kalbani, Judit Bene, Sebestyén Kovács, László Mangel, Kinga Hadzsi |
| Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer. BMC cancer 2024 8 24 (1): 1000. Yasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Tazuko Inoue, Fumie Fujisawa, Kazuyoshi Ohka |
| BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? Frontiers in oncology 2024 7 14 1414343. Daniele Fanale, Lidia Rita Corsini, Chiara Brando, Ugo Randazzo, Marco Bono, Erika Pedone, Alessandro Perez, Roberta Sciacchitano, Daniela Cancelliere, Paola Piraino, Ambra Giurintano, Tancredi Didier Bazan Russo, Pietro Ferraro, Gaetana Rinaldi, Valeria Spinnato, Vincenzo Gennusa, Gianfranco Pernice, Salvatore Vieni, Gianni Pantuso, Antonio Russo, Viviana Baz |
| In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes 2024 7 15 (7): . Stefania Stella, Silvia Rita Vitale, Michele Massimino, Federica Martorana, Irene Tornabene, Cristina Tomarchio, Melissa Drago, Giuliana Pavone, Cristina Gorgone, Chiara Barone, Sebastiano Bianca, Livia Manzel |
| Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers 2024 7 16 (14): . Ava Kwong, Cecilia Y S Ho, Chun-Hang Au, Edmond S K |
| The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation. Journal of gynecologic oncology 2024 7 . Yeon Jee Lee, Ji Hyun Kim, Youn Jee Kim, Yoon Jung Chang, Sun-Young Kong, Chong Woo Yoo, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol L |
| High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands. Breast cancer (Tokyo, Japan) 2024 7 . Reiko Yoshida, Tomoko Kaneyasu, Arisa Ueki, Hideko Yamauchi, Shozo Ohsumi, Shinji Ohno, Daisuke Aoki, Shinichi Baba, Junko Kawano, Naomichi Matsumoto, Masao Nagasaki, Takayuki Ueno, Hitoshi Inari, Yusuke Kobayashi, Junko Takei, Osamu Gotoh, Mitsuyo Nishi, Miki Okamura, Keika Kaneko, Megumi Okawa, Misato Suzuki, Sayuri Amino, Mayuko Inuzuka, Tetsuo Noda, Seiichi Mori, Seigo Nakamu |
| Incidence of Peritoneal Cancer Following Oophorectomy among BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute 2024 6 . Steven A Narod, Jacek Gronwald, Beth Karlan, Pal Moller, Tomasz Huzarski, Nadine Tung, Amber Aeilts, Andrea Eisen, Susan Randall Armel, Christian F Singer, William D Foulkes, Susan L Neuhausen, Olufunmilayo Olopade, Tuya Pal, Robert Fruscio, Kelly Metcalfe, Rebecca Raj, Michelle Jacobson, Ping Sun, Jan Lubinski, Joanne Kotsopoul |
| Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC). Urologic oncology 2024 6 . Sara Custodio-Cabello, Vilma Pacheco-Barcia, Magda Palka-Kotlowska, Laura Fernández-Hernández, Julio Fernández Del Álamo, Eduardo Oliveros-Acebes, Luis Cabezón-Gutiérr |
| Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024 12 51 (3): 109380. Quratul Ain, Rachel L O'Connell, Parinita Swarnkar, Terri McVeigh, Angela George, Marios K Tasoulis, Gerald Ph Gui, Jennifer Wiggins, Aadil A Khan, Katherine Dc Krupa, Peter A Barry, Susana Banerjee, Jennifer E Rus |
| Contribution of large genomic rearrangements in BRCA1/2 genes and CHEK2 1100delC allele variant to the development of breast/ovarian cancer in Argentinian population. Breast cancer research and treatment 2024 12 . Luciana Berlanga, Vanesa Lotersztein, Eliseo I Aranda, Roxana Cerreti |
| Patterns of genomic instability in?>?2000 patients with ovarian cancer across six clinical trials evaluating olaparib. Genome medicine 2024 12 16 (1): 145. Alan Barnicle, Isabelle Ray-Coquard, Etienne Rouleau, Karen Cadoo, Fiona Simpkins, Carol Aghajanian, Alexandra Leary, Andrés Poveda, Stephanie Lheureux, Eric Pujade-Lauraine, Benoit You, Jonathan Ledermann, Ursula Matulonis, Charlie Gourley, Kirsten M Timms, Zhongwu Lai, Darren R Hodgson, Cathy E Elks, Simon Dearden, Coumaran Egile, Pierre Lao-Sirieix, Elizabeth A Harrington, Jessica S Bro |
| Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. International journal of molecular sciences 2024 12 25 (23): . Petra Nagy, János Papp, Vince Kornél Grolmusz, Anikó Bozsik, Tímea Pócza, Edit Oláh, Attila Patócs, Henriett Bu |
| Clinical Outcomes of Poly(ADP-Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea. Current oncology (Toronto, Ont.) 2024 11 31 (11): 6711-6722. Hyeong In Ha, Hyung Joon Yoon, Changho Song, Eun Taeg Kim, Dong-Soo Suh, Ki Hyung Kim, Yong Jin Na, Yong Jung So |
| Homologous recombination deficiency in pancreatic neuroendocrine tumors. Future oncology (London, England) 2024 11 1-10. Camilla Bardasi, Elena Tenedini, Lia Bonamici, Stefania Benatti, Luca Reggiani Bonetti, Gabriele Luppi, Laura Cortesi, Enrico Tagliafico, Massimo Dominici, Fabio Gelsomi |
| High Rates of Germline Pathogenic Variants in Somali Patients with Ovarian Cancer. Gynecologic oncology reports 2024 11 56 101538. José V Somohano-Short, Natasha Crawford, Mahmoud A Khalifa, Britt K Ericks |
| Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome. JCO global oncology 2024 11 10 e2400352. Rifaat R Rawashdeh, Holly Pederson, Rafal Iskanderian, Fawad Khan, Basel Altrabulsi, Stephanie Ricci, Charis Eng, Bassel Jallad, Asma Ibrahim Al Mannaei, Mohamed Salem Alameri, Azza Attia, Stephen R Grobmy |
| The discrepancy of somatic BRCA1/2 pathogenic variants from two different platforms in epithelial ovarian, fallopian tube, and peritoneal cancer. Scientific reports 2024 10 14 (1): 25879. Ji Hyun Kim, Jun-Young Shin, Seog-Yun Park, Sang-Soo Seo, Sokbom Kang, Chong Woo Yoo, Sang-Yoon Park, Myong Cheol L |
| PALB2 analysis in the diagnostic process of breast cancer: An Italian monocentric experience. Tumori 2024 10 3008916241290738. Maria Grazia Tibiletti, Ileana Carnevali, Sofia Facchi, Laura Libera, Corrado Chiappa, Fausto Sessa, Stefano La Rosa, Francesca Rove |
| Two founder variants account for over 90% of pathogenic BRCA alleles in the Orkney and Shetland Isles in Scotland. European journal of human genetics : EJHG 2024 10 . Shona M Kerr, Lucija Klaric, Marisa D Muckian, Emma Cowan, Lesley Snadden, Gannie Tzoneva, Alan R Shuldiner, Zosia Miedzybrodzka, James F Wils |
| Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers. Revista da Associacao Medica Brasileira (1992) 2024 10 70 (10): e20240534. Ferah Kazanci, Zerrin Y?lmaz Çelik, Mert Polat, Ferhat Karademir, Ozlem Erdem, Feride ?ffet ?ahin, Mehmet Anil On |
| Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data. Breast cancer research and treatment 2024 10 . Nana Komatsu, Takashi Chishima, Chie Watanabe, Kanae Taruno, Mayuko Inuzuka, Masanori Oshi, Masami Arai, Seigo Nakamu |
| Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population. Breast cancer research : BCR 2025 1 27 (1): 7. Dione Aguilar, María Lourdes Garza-Rodríguez, Carolina Elizabeth Muñiz-Garza, Fernando Alcorta Nuñez, Cynthia Mayte Villarreal-Garza, Oscar Vidal-Gutiérrez, Diana Cristina Pérez-Ibave, Carlos Horacio Burciaga-Flor |
- Page last reviewed:Feb 1, 2024
- Content source: